Why the study?
Mid-ventricular hypertrophic cardiomyopathy with apical aneurysm is a rare subgroup associated with an increased risk of adverse cardiac events including sudden cardiac death.
Multimodality imaging is crucial for the accurate diagnosis of mid-ventricular hypertrophic cardiomyopathy with apical aneurysm and for guiding sudden cardiac death risk stratification for ICD implantation.
Answers are grounded in this paper and cite their sources.
Raises awareness of adverse risks in mid-ventricular HCM with aneurysm; hypothesis-generating for risk stratification and management.
Mid-ventricular hypertrophic cardiomyopathy is a rare subgroup within hypertrophic cardiomyopathies that may present with apical aneurysm. This condition is associated with an increased risk of cardiac adverse events, including cardiac arrest, heart failure, thromboembolic events, or sudden cardiac death. We present a case of a 41-year-old man who presented with a history of exertional dyspnea and syncope. Multimodality imaging with echocardiography and cardiac magnetic resonance showed hypertrophy of the mid-ventricular segments with apical aneurysm. An implantable cardioverter-defibrillator was implanted to prevent sudden cardiac death.
No takes yet. Share an insight, caveat, or question.
Martinez‐Dominguez et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: